OXFD
$13.64
Oxford Immunotec
($.48)
(3.40%)
OXFD
Earnings Whisper ®
N/A
4th Quarter December 2019
Consensus:  ($0.11)
Revenue:  $17.10 Mil
Monday
Mar 2
7:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when OXFD reports earnings?
Beat
Meet
Miss

Where is OXFD's stock price going from here?
Up
Flat
Down
Stock chart of OXFD
Analysts
Summary of analysts' recommendations for OXFD
Score
Grade
Pivots
Resistance
$14.87
$14.63
$14.38

$14.14

Support
$13.89
$13.65
$13.40
Tweet
Growth
Description
Oxford Immunotec Global PLC is a medical diagnostics company. It develops new tests for various diseases based on its, patented T cell measurement technology. The company's first product is the T-SPOT(R). Oxford Immunotec Global PLC is headquartered in Abingdon, the United Kingdom.